CERUS CORP (CERS) 8-K Current Report: March 16, 2026
Filed: March 16, 2026
Health Care
Surgical & Medical Instruments & ApparatusCERUS CORP (CERS) 8-K current report filed with SEC EDGAR on March 16, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.
Reported 8-K Items1 item
- Item 5.02: Departure/Election of Directors or Officers
CERUS CORP 8-K Mar 16, 2026 Event Analysis
Item 5.02 · Departure/Election of Directors or Officers
- • Vivek Jayaraman promoted from COO to President & CEO effective July 1, 2026; 6-year internal veteran with commercial and operational background
- • Outgoing CEO Obi Greenman transitions to Executive Chairman — continuity signal but also a governance overhang to watch
- • New CEO base salary $740,000; target bonus 80% of base ($592K) for 2027+; promotion equity package totals $3M ($2M Promotion Award + $1M Achievement Award)
- • Equity floor protection: share count for awards calculated at minimum $2.50/share, suggesting stock is near or below that level — dilution risk capped but signals depressed valuation
- • Severance: 12-month base salary + COBRA + full equity acceleration on qualifying termination, including change-in-control within 12 months — meaningful M&A protection embedded
Other CERUS CORP 8-K Filings
Get deeper insights on CERUS CORP
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.